Comprehensive Guide to WHO Recommendations for Effective HIV Treatment

Review of WHO’s Commitment to Ending the AIDS Epidemic

Progress and Challenges in HIV Treatment

A recent review by Swiss researchers examined the World Health Organization’s (WHO) global initiative to eradicate the AIDS epidemic by 2030 and the obstacles to effective HIV treatment. In 2006, approximately 1.3 million individuals in low- and middle-income countries were receiving antiretroviral treatment (ART). Within this group, there was significant variability in diagnostic methods, the specific medications administered to HIV-positive patients, and the delivery of treatment. To standardize and enhance access to HIV treatment, the WHO introduced a public health strategy aimed at expanding ART availability in resource-limited settings, with the goal of eliminating AIDS as a public health threat by 2030.

While the WHO’s vision has laid a strong foundation for scaling up HIV treatment, several challenges persist. These include the need for improved testing methods for HIV diagnosis, simplified treatment protocols, and enhanced monitoring. Additionally, it is crucial to link testing and HIV treatment with prevention efforts. The WHO’s strategy has necessitated implementing key public health principles in various countries to progress toward controlling the HIV epidemic.

Progress in HIV Treatment

By the end of 2016, over 19.5 million individuals were reported to be receiving ART, leading to a life expectancy for those living with HIV that is comparable to the general population, thanks to advancements in effective treatments. There have been significant scientific breakthroughs alongside diagnostic innovations, resulting in the approval of 16 new antiretroviral medications and combinations by the FDA for HIV treatment. Moreover, the cost of first-line therapy has dramatically decreased from over $10,000 to less than $100 per patient annually.

HIV Treatment in Primary Care

The shift from specialist centers to primary care facilities for HIV treatment has significantly improved outcomes for both adults and children. Despite initial hesitations to decentralize and integrate ART at the primary care level, growing evidence of enhanced clinical outcomes—particularly in high-risk populations—has led many countries to adopt this WHO recommendation.

The implementation of WHO guidelines established in 2006 has been credited with averting an estimated 7.8 million deaths and preventing approximately 30 million new HIV infections, particularly in high-risk populations in low- and middle-income countries. Moving forward, the focus must shift towards increasing prevention efforts, which includes long-term virus control and reducing transmission rates.

The 90-90-90 Target

To expedite progress, the WHO set an ambitious target known as 90-90-90 by 2020. This goal entails that 90% of all individuals living with HIV are aware of their status, 90% of diagnosed HIV-positive individuals receive treatment, and 90% of those on sustained ART achieve viral suppression. Meeting this target could save over 21 million lives and prevent 28 million new infections over the next 15 years.

Simplification and Standardization of Treatment

Central to this approach is the simplification and standardization of treatment regimens, clinical decision-making, and monitoring. The recommended first-line ART for most patients is a once-daily single pill, a factor to consider when introducing new drugs and regimens. However, improvements are still needed in managing treatment failures, as there are currently no once-daily or fixed combinations available for second-line treatment, which poses adherence challenges for patients.

Significant strides have been made in HIV prevention, driven by effective behavioral strategies such as early ART initiation, voluntary male circumcision, and pre-exposure prophylaxis. However, the implementation and adherence to these prevention strategies remain low. To achieve the goal of ending the AIDS epidemic by 2030, there must be an acceleration of prevention interventions, particularly through the integration of HIV testing, treatment, and care.

Conclusion

The evolution of public health strategies aimed at enhancing HIV treatment and clinical outcomes since the WHO’s vision in 2006 has been substantial. Nevertheless, to successfully end the AIDS epidemic by 2030, evidence from this review indicates that considerable work remains. The outlined approaches are vital and emphasize the necessity for countries, especially those at high risk, to adopt essential public health principles in ART delivery and care to move closer to controlling the epidemic and ultimately achieving universal health coverage.

Written by Lacey Hizartzidis, PhD
Reference: Ford N, Ball A, Baggaley R, Vitoria M, Low-Beer D, Penazzato M, Vojnov L, Bertagnolio S, Habiyambere V, Doherty M, Hirnschall G. The WHO public health approach to HIV treatment and care: looking back and looking ahead. Lancet Infect Dis. 2018 Mar;18(3):e76-e86. doi: 10.1016/S1473-3099(17)30482-6.